Effects of DES Platforms on Markers of Endothelial Damage and Inflammation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT01489202
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose diagnostic
- Phase
- Phase 4
- Enrolled
- 100 participants
- Registry
-
NCT01489202
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Unknown status
Technical summary
Registry record NCT01489202. Randomized; single masking; primary purpose diagnostic. Start 2014-09 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effects of DES Platforms on Markers of Endothelial Damage and Inflammation
- Acronym
- PLATFORM
- Condition
- Coronary Artery Disease
- Intervention (Device)
- platinum chromium everolimus-eluting stent
- Intervention (Device)
- cobalt chromium everolimus-eluting stent
- Lead sponsor
- University of Roma La Sapienza
Record details
- Record id
cardio:ct-nct01489202- Content hash
bc552f1baeaa9ef95c1dd6258e114ca896b1756b62dea93ed792ac8ca8e57fa9